Modern Vaccines/Adjuvants Formulation--Session 2 (Plenary II): May 15-17, 2013--Lausanne, Switzerland.

MLA

Collin, Nicolas. “Modern Vaccines/Adjuvants Formulation--Session 2 (Plenary II): May 15-17, 2013--Lausanne, Switzerland.” Human Vaccines & Immunotherapeutics, vol. 9, no. 9, Sept. 2013, pp. 2015–16. EBSCOhost, https://doi.org/10.4161/hv.26208.

APA

Collin, N. (2013). Modern Vaccines/Adjuvants Formulation--Session 2 (Plenary II): May 15-17, 2013--Lausanne, Switzerland. Human Vaccines & Immunotherapeutics, 9(9), 2015–2016. https://doi.org/10.4161/hv.26208

Chicago

Collin, Nicolas. 2013. “Modern Vaccines/Adjuvants Formulation--Session 2 (Plenary II): May 15-17, 2013--Lausanne, Switzerland.” Human Vaccines & Immunotherapeutics 9 (9): 2015–16. doi:10.4161/hv.26208.